论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhang Y, Qiao W, Shan L
Received 14 January 2018
Accepted for publication 7 April 2018
Published 11 June 2018 Volume 2018:11 Pages 3385—3393
DOI https://doi.org/10.2147/OTT.S162523
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 3
Editor who approved publication: Dr Yao Dai
Objectives: FOXM1 is a key member of the FOX transcription factor family,
which plays a vital role in a series of physiological processes. In the present
study, non-small cell lung cancer (NSCLC) patients and cell lines were studied
to explore the correlation between FOXM1 expression and this malignancy.
Materials and methods: The expression status of FOXM1 was detected in
128 cases of NSCLC tissues and NSCLC cell lines. The relationship of FOXM1
expression and clinicopathological features of NSCLC patients was evaluated by
us. In addition, we also explored the biological functions of FOXM1 in NSCLC
cell lines.
Results: The FOXM1 is highly expressed in NSCLC tissues
and cell lines. FOXM1 expression was closely correlated with lymph node status
and TNM stage. Cox regression analysis were performed to demonstrate the
prognosis role of FOXM1.
Conclusion: FOXM1 conferred a proliferation and invasion
advantage to NSCLC cell. The FOXM1 can be regarded as an important molecular
marker in NSCLC prognosis.
Keywords: non-small cell
lung cancer, FOXM1, proliferation, prognosis
